Close Menu

CHICAGO (GenomeWeb) – Envisagenics, a startup focused on aiding drug discovery by applying artificial intelligence to gene sequences, has closed a $2.4 million seed round of venture capital.

The lead investors are mostly women, including Daniella Kranjac, managing director of Dynamk Capital; Shana Fisher, founder of Third Kind Venture Capital; and Gillian Sandler, of New York biotech investment company Cosine, the firm said. Envisagenics also received funding from Peter Thiel's Breakout Labs and from the New York State Innovation Venture Capital Fund.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.